If technology-enabled visibility isn’t built into the pharma supply chain today, then manufacturers, distributors, wholesalers, shippers and pharmacies risk significant losses.
From marketing consultants and supply-chain partners to accountants and IT service providers, organizations today depend on all kinds of third parties for virtually every conceivable business function.
Digital transformation within the supply chain is well underway. But consumer-products companies are lagging many other industries in progressing toward that goal.
The meteoric rise of business-to-consumer retail e-commerce has sent shock waves throughout the industry. Now, the impact is reverberating beyond Amazon and eBay to affect business-to-business companies everywhere.
The past decade has seen a monumental shift in the requirements placed on distribution centers. As customers continue to trend toward online sales and demand faster delivery times, retailers and wholesalers are feeling the pressure.
The trade standoff between the U.S. and China has yet to seriously impact the pharmaceutical and life sciences industries. But as neither side shows signs of backing down, and tariffs continue to be levied on virtually every segment, those sectors are preparing for a major supply-chain disruption.
More than 50% of companies are using big-data analytics, a recent survey says, but a closer look reveals that adoption rate varies significantly by industry.
Everywhere you turn these days, there’s a blockchain pilot underway for the supply chain. But they’re all missing one crucial element: a single, coherent set of standards.